Yan Xia
Impact in
-
- Neuroscience and Neuropharmacology Research
- Neuropeptides and Animal Physiology
- Neurotransmitter Receptor Influence on Behavior
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
Papers in
-
- RNA modifications and cancer 4
- Oncology 17
- Co-authors
- Kenneth M. Johnson (2 shared papers)Cheng Z. Wang (3 shared papers)Vsevolod Katritch (1 shared paper)Hyekyung P. Cho (1 shared paper)Jens Meiler (1 shared paper)Gye Won Han (1 shared paper)Huixian Wu (1 shared paper)Colleen M. Niswender (1 shared paper)
- Journals
- Neuropsychopharmacology (3 papers)European Journal of Neuroscience (2 papers)OncoTargets and Therapy (2 papers)Annals of Translational Medicine (2 papers)BMC Complementary and Alternative Medicine (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yan Xia
69 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Cellular and Molecular Neuroscience 532
- Biological Psychiatry 53
- Developmental Neuroscience 61
- Molecular Biology 788
- Cancer Research 114
Countries citing papers authored by Yan Xia
This map shows the geographic impact of Yan Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Xia more than expected).
Fields of papers citing papers by Yan Xia
This network shows the impact of papers produced by Yan Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Xia. The network helps show where Yan Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator Hit paper breakdown → | 2014 | 405 |
| 2 | 2007 | 122 | |
| 3 | 2007 | 57 | |
| 4 | 2009 | 50 | |
| 5 | 2014 | 49 | |
| 6 | 2006 | 43 | |
| 7 | 2011 | 41 | |
| 8 | 2019 | 33 | |
| 9 | 2018 | 32 | |
| 10 | 2015 | 31 | |
| 11 | 2018 | 30 | |
| 12 | 2015 | 27 | |
| 13 | HSF2 regulates aerobic glycolysis by suppression of FBP1 in hepatocellular carcinoma. | 2019 | 25 |
| 14 | 2017 | 24 | |
| 15 | 2010 | 24 | |
| 16 | 2015 | 23 | |
| 17 | 2020 | 23 | |
| 18 | 2008 | 22 | |
| 19 | 2018 | 20 | |
| 20 | 2012 | 19 |
About Yan Xia
Yan Xia is a scholar working on Molecular Biology, Oncology, Surgery, Pulmonary and Respiratory Medicine and Cellular and Molecular Neuroscience, having authored 75 papers that have together received 1.4k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cancer Mechanisms and Therapy (4 papers), RNA modifications and cancer (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Myasthenia Gravis and Thymoma (4 papers) and Anesthesia and Neurotoxicity Research (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (532 citations), Biological Psychiatry (53 citations), Developmental Neuroscience (61 citations), Molecular Biology (788 citations) and Cancer Research (114 citations). Yan Xia has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Kenneth M. Johnson, Cheng Z. Wang, Vsevolod Katritch, Hyekyung P. Cho, Jens Meiler, Gye Won Han, Huixian Wu, Colleen M. Niswender, P. Jeffrey Conn and Vadim Cherezov. Their work appears in journals such as Neuropsychopharmacology, European Journal of Neuroscience, OncoTargets and Therapy, Annals of Translational Medicine and BMC Complementary and Alternative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.